Pfizer/BioNTech and Moderna to supply EU with more doses

February 17, 2021

Between both Covid-19 vaccines, an additional 350 million doses are being sent to Europe this year

Pfizer Inc. and BioNTech SE have reached an agreement with the European Commission (EC) to supply an additional 200 million doses of their Covid-19 vaccine to the 27 European Union (EU) member states. The EC has the option to request supply of an additional 100 million doses.

This new deal supplements the 300 million doses that have already been committed to the EU through 2021 under the first supply agreement signed late last year. The additional 200 million doses are expected to be delivered in 2021, with an estimated 75 million to be supplied in Q2.

The total number of Pfizer/BioNTech doses to be delivered to the EU member states by the end of 2021 is now 500 million, with the potential to increase to 600 million based on the option granted in the new agreement.

The EC has also purchased an additional 150 million doses of the Moderna vaccine, which are scheduled to be delivered in Q3 and Q4. This brings its confirmed order commitment to 310 million doses for delivery in 2021.

Per the agreement, the EC has the option to purchase an additional 150 million doses to be delivered in 2022.